{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T07:08:06Z","timestamp":1794812886458,"version":"4.9.1"},"reference-count":161,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JJ30595"],"award-info":[{"award-number":["2021JJ30595"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JJ50096"],"award-info":[{"award-number":["2021JJ50096"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.heliyon.2024.e39217","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T22:45:05Z","timestamp":1728600305000},"page":"e39217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Unveiling the multifaceted pathogenesis and therapeutic drugs of Alzheimer's disease: A comprehensive review"],"prefix":"10.1016","volume":"10","author":[{"given":"Liting","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7440-2622","authenticated-orcid":false,"given":"Zhiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canqun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-2177","authenticated-orcid":false,"given":"Hongyan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e39217_bib1","year":"2018","journal-title":"World Alzheimer Report 2018 The state of the art of dementia research: New frontiers"},{"key":"10.1016\/j.heliyon.2024.e39217_bib2","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123431","article-title":"BACE2, a conditional beta-secretase, contributes to Alzheimer's disease pathogenesis","volume":"4","author":"Wang","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.heliyon.2024.e39217_bib3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases","volume":"6","author":"Selkoe","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.114.512.797","article-title":"The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects","volume":"114","author":"Blessed","year":"1968","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e39217_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0006-8993(74)90798-7","article-title":"Protein changes in senile dementia","volume":"77","author":"Iqbal","year":"1974","journal-title":"Brain Res."},{"key":"10.1016\/j.heliyon.2024.e39217_bib6","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.18632\/aging.102785","article-title":"Identifying lncRNA-miRNA-mRNA networks to investigate Alzheimer's disease pathogenesis and therapy strategy","volume":"12","author":"Ma","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.heliyon.2024.e39217_bib7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2166040","article-title":"Dual-target ligand discovery for Alzheimer's disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and beta-amyloid aggregation","volume":"38","author":"El-Hussieny","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.heliyon.2024.e39217_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e39217_bib10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","article-title":"Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review","volume":"36","author":"Butterfield","year":"2002","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.heliyon.2024.e39217_bib11","article-title":"Iron dyshomeostasis and ferroptosis: a new Alzheimer's disease hypothesis?","volume":"14","author":"Wang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib12","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","article-title":"Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation","volume":"71","author":"Chen","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2024.e39217_bib13","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2174\/1570159X19666211201094031","article-title":"BACE1: a key regulator in Alzheimer's disease progression and current development of its inhibitors","volume":"20","author":"Patel","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13399","article-title":"Cerebrospinal fluid biomarkers in the longitudinal early-onset Alzheimer's disease study","author":"Dage","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.heliyon.2024.e39217_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094568","article-title":"PTPRD and dcc are novel BACE1 substrates differentially expressed in Alzheimer's disease: a data mining and bioinformatics study","volume":"23","author":"Taylor","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","article-title":"The beta-Secretase BACE1 in Alzheimer's Disease","volume":"89","author":"Hampel","year":"2021","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e39217_bib17","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1073\/pnas.1800498115","article-title":"BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer's disease","volume":"115","author":"Bao","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.heliyon.2024.e39217_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/med.21622","article-title":"BACE1 inhibitors: current status and future directions in treating Alzheimer's disease","volume":"40","author":"Moussa-Pacha","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.heliyon.2024.e39217_bib19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1073858420940943","article-title":"The ups and downs of BACE1: walking a fine line between neurocognitive and other psychiatric symptoms of Alzheimer's disease","volume":"27","author":"Ovsepian","year":"2021","journal-title":"Neuroscientist"},{"key":"10.1016\/j.heliyon.2024.e39217_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajpath.2011.09.034","article-title":"BACE2 expression increases in human neurodegenerative disease","volume":"180","author":"Holler","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib21","first-page":"34","article-title":"Cellular smears in the diagnosis of oral pemphigus]","volume":"21","author":"Sha","year":"1986","journal-title":"Zhonghua Kou Qiang Ke Za Zhi"},{"key":"10.1016\/j.heliyon.2024.e39217_bib22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/jnc.15940","article-title":"BACE2 beyond beta-processing of APP, its neuroprotective role in cerebrovascular endothelium","volume":"166","author":"Saez-Valero","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.heliyon.2024.e39217_bib23","doi-asserted-by":"crossref","first-page":"20647","DOI":"10.1074\/jbc.M002688200","article-title":"Expression analysis of BACE2 in brain and peripheral tissues","volume":"275","author":"Bennett","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e39217_bib24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.heliyon.2024.e39217_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126355","article-title":"Neurotoxic soluble amyloid oligomers drive Alzheimer's pathogenesis and represent a clinically validated target for slowing disease progression","volume":"22","author":"Tolar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ebiom.2019.03.049","article-title":"Toxic amyloid-beta oligomers induced self-replication in astrocytes triggering neuronal injury","volume":"42","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.heliyon.2024.e39217_bib27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41420-023-01739-w","article-title":"A delay in vesicle endocytosis by a C-terminal fragment of N-cadherin enhances Abeta synaptotoxicity","volume":"9","author":"Teng","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.heliyon.2024.e39217_bib28","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1152993","article-title":"Differential regulation of dynein and kinesin motor proteins by tau","volume":"319","author":"Dixit","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e39217_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47249-7","article-title":"Differential binding affinity of tau repeat region R2 with neuronal-specific beta-tubulin isotypes","volume":"9","author":"Bhandare","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e39217_bib30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1021\/acschemneuro.2c00611","article-title":"Phosphorylation of tau R2 repeat destabilizes its binding to microtubules: a molecular dynamics simulation study","volume":"14","author":"Man","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","article-title":"\"Don't Phos over Tau\": recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies","volume":"16","author":"Xia","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.heliyon.2024.e39217_bib32","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between abeta and tau in the pathogenesis of Alzheimer's disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/nan.12084","article-title":"Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome","volume":"40","author":"Mondragon-Rodriguez","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1039\/D2DT02838G","article-title":"Coordination properties of Cu(II) ions towards a phosphorylated fragment from the R1 domain of the tau protein and the effect of Ser phosphorylation on Cu(II) binding affinity","volume":"52","author":"Kyriakou","year":"2022","journal-title":"Dalton Trans."},{"key":"10.1016\/j.heliyon.2024.e39217_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/abbi.1998.0813","article-title":"Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules","volume":"357","author":"Sengupta","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.heliyon.2024.e39217_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl8809","article-title":"Alzheimer's disease: ablating single master site abolishes tau hyperphosphorylation","volume":"8","author":"Stefanoska","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.heliyon.2024.e39217_bib37","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1523\/JNEUROSCI.1074-10.2010","article-title":"Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons","volume":"30","author":"Decker","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib38","doi-asserted-by":"crossref","first-page":"10480","DOI":"10.1523\/JNEUROSCI.3231-06.2006","article-title":"Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons","volume":"26","author":"Rui","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1006807105059","article-title":"Protein kinase C and calcium\/calmodulin-dependent protein kinase II phosphorylate three-repeat and four-repeat tau isoforms at different rates","volume":"168","author":"Singh","year":"1997","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.heliyon.2024.e39217_bib40","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/brain\/awab134","article-title":"Amyloid-beta toxicity modulates tau phosphorylation through the PAX6 signalling pathway","volume":"144","author":"Zhang","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.heliyon.2024.e39217_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073495","article-title":"Phosphorylation but not oligomerization drives the accumulation of tau with nucleoporin Nup98","volume":"23","author":"Diez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bfgp\/elac022","article-title":"Tau-FG-nucleoporin98 interaction and impaired nucleocytoplasmic transport in Alzheimer's disease","volume":"22","author":"Nag","year":"2023","journal-title":"Brief Funct Genomics"},{"key":"10.1016\/j.heliyon.2024.e39217_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer's disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118826","article-title":"Revisiting the role of neurotransmitters in epilepsy: an updated review","volume":"265","author":"Akyuz","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3233\/JAD-150327","article-title":"AbetaPP-Transgenic 2576 mice mimic cell type-specific aspects of acetyl-CoA-linked metabolic deficits in Alzheimer's disease","volume":"48","author":"Bielarczyk","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.heliyon.2024.e39217_bib46","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3233\/JAD-160702","article-title":"Mitochondrial dysfunction and synaptic transmission failure in Alzheimer's disease","volume":"57","author":"Guo","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.heliyon.2024.e39217_bib47","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.14336\/AD.2019.1125","article-title":"Relationships between mitochondrial dysfunction and neurotransmission failure in Alzheimer's disease","volume":"11","author":"Wong","year":"2020","journal-title":"Aging Dis"},{"key":"10.1016\/j.heliyon.2024.e39217_bib48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12264-013-1406-z","article-title":"M1 muscarinic acetylcholine receptor in Alzheimer's disease","volume":"30","author":"Jiang","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.heliyon.2024.e39217_bib49","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1523\/JNEUROSCI.6393-09.2010","article-title":"Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo","volume":"30","author":"Davis","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib50","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1006\/bbrc.1994.2232","article-title":"Amyloid precursor protein secretion via muscarinic receptors: reduced desensitization using the M1-selective agonist AF102B","volume":"203","author":"Haring","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e39217_bib51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","article-title":"M1 receptors play a central role in modulating AD-like pathology in transgenic mice","volume":"49","author":"Caccamo","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.heliyon.2024.e39217_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0928-4257(98)80140-X","article-title":"Allosteric nicotinic receptors, human pathologies","volume":"92","author":"Lena","year":"1998","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.heliyon.2024.e39217_bib53","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/BF00965590","article-title":"Subcellular fractionation and distribution of cholinergic binding sites in fetal human brain","volume":"11","author":"Whyte","year":"1986","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.heliyon.2024.e39217_bib54","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.1523\/JNEUROSCI.18-18-07075.1998","article-title":"Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission","volume":"18","author":"Radcliffe","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib55","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/383713a0","article-title":"Hippocampal synaptic transmission enhanced by low concentrations of nicotine","volume":"383","author":"Gray","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e39217_bib56","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1749-6632.1999.tb11332.x","article-title":"Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons","volume":"868","author":"Radcliffe","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib57","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1126\/science.7569895","article-title":"Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors","volume":"269","author":"McGehee","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e39217_bib58","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/BF02532425","article-title":"Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes","volume":"21","author":"Wilkie","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.heliyon.2024.e39217_bib59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1476-5381.1996.tb15232.x","article-title":"Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release","volume":"117","author":"Clarke","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/syn.890160105","article-title":"Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area","volume":"16","author":"Nisell","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.heliyon.2024.e39217_bib61","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-3565(25)12298-2","article-title":"Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons","volume":"276","author":"Yang","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.heliyon.2024.e39217_bib62","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.apsb.2020.05.005","article-title":"Interacting with alpha 7 nAChR is a new mechanism for AChE to enhance the inflammatory response in macrophages","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.heliyon.2024.e39217_bib63","article-title":"Role of cholinergic signaling in Alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e39217_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9982954","article-title":"Inflammation and Alzheimer's disease: mechanisms and therapeutic implications by natural products","volume":"2021","author":"Rather","year":"2021","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.heliyon.2024.e39217_bib65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","article-title":"Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain","volume":"39","author":"Lawson","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.heliyon.2024.e39217_bib66","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2174\/1570159X18666201111104509","article-title":"Glia-driven neuroinflammation and systemic inflammation in Alzheimer's disease","volume":"19","author":"Hashioka","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib67","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib68","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.heliyon.2024.e39217_bib69","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e39217_bib70","article-title":"The effects of microglia-associated neuroinflammation on Alzheimer's disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib71","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer's disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e39217_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112990","article-title":"Microglia and Alzheimer's disease","volume":"23","author":"Merighi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib73","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10571-014-0101-6","article-title":"Microglial Abeta receptors in Alzheimer's disease","volume":"35","author":"Yu","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib74","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1113\/JP272134","article-title":"Microglia across the lifespan: from origin to function in brain development, plasticity and cognition","volume":"595","author":"Tay","year":"2017","journal-title":"J Physiol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib75","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature09513","article-title":"Pericytes are required for blood-brain barrier integrity during embryogenesis","volume":"468","author":"Daneman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e39217_bib76","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/mds.27718","article-title":"The A1 astrocyte paradigm: new avenues for pharmacological intervention in neurodegeneration","volume":"34","author":"Hinkle","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2024.e39217_bib77","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/glia.23467","article-title":"Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes","volume":"66","author":"Neal","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.heliyon.2024.e39217_bib78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s12276-023-01148-0","article-title":"Pathological phenotypes of astrocytes in Alzheimer's disease","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e39217_bib79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e39217_bib80","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2174\/1570159X15666170720095240","article-title":"Microglia and astrocytes in Alzheimer's disease: implications for therapy","volume":"16","author":"Fakhoury","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib81","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.heliyon.2024.e39217_bib82","doi-asserted-by":"crossref","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","article-title":"Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature","volume":"2","author":"Wyss-Coray","year":"2012","journal-title":"Cold Spring Harb Perspect Med."},{"key":"10.1016\/j.heliyon.2024.e39217_bib83","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnagi.2016.00160","article-title":"Mechanisms of abeta clearance and degradation by glial cells","volume":"8","author":"Ries","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094850","article-title":"Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer's disease","volume":"22","author":"Sharma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib85","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.617588","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer's disease","volume":"13","author":"Misrani","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib87","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/ars.2016.6925","article-title":"Redox signaling mediated by thioredoxin and glutathione systems in the central nervous system","volume":"27","author":"Ren","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.heliyon.2024.e39217_bib88","first-page":"116","article-title":"Spatial regulation of homeo box gene expression in Drosophila","volume":"4","author":"Levine","year":"1987","journal-title":"Oxf Surv Eukaryot Genes."},{"key":"10.1016\/j.heliyon.2024.e39217_bib89","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e39217_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11112167","article-title":"The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer's disease: therapeutic implications and future perspectives","volume":"11","author":"Jurcau","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.heliyon.2024.e39217_bib91","article-title":"Human wild-type full-length tau accumulation disrupts mitochondrial dynamics and the functions via increasing mitofusins","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e39217_bib92","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/hmg\/ddx381","article-title":"Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease","volume":"27","author":"Kandimalla","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2024.e39217_bib93","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1038\/s41467-019-11813-6","article-title":"Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer's disease","volume":"10","author":"Jadiya","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e39217_bib94","first-page":"273","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism","volume":"171","author":"Stockwell","year":"2017","journal-title":"Redox Biology, and Disease, Cell"},{"key":"10.1016\/j.heliyon.2024.e39217_bib95","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pbiomolbio.2020.04.001","article-title":"Ferroptosis as an emerging target in inflammatory diseases","volume":"155","author":"Mao","year":"2020","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib96","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1476-5381.2011.01480.x","article-title":"System xc(-) cystine\/glutamate antiporter: an update on molecular pharmacology and roles within the CNS","volume":"165","author":"Bridges","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib97","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/s41380-019-0375-7","article-title":"Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology","volume":"25","author":"Ayton","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e39217_bib98","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-981-13-9589-5_2","article-title":"Cellular iron metabolism and regulation","volume":"1173","author":"Gao","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib99","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib100","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","article-title":"Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease","volume":"28","author":"Bao","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.heliyon.2024.e39217_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101947","article-title":"NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases","volume":"41","author":"Park","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib102","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/ana.26770","article-title":"Ferroptosis of microglia in aging human white matter injury","volume":"94","author":"Adeniyi","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib103","first-page":"77","article-title":"Mitophagy, ferritinophagy and ferroptosis in retinal pigment epithelial cells under high glucose conditions: implications for diabetic retinopathy and age-related retinal diseases","volume":"8","author":"Singh","year":"2021","journal-title":"JOJ Ophthalmol"},{"key":"10.1016\/j.heliyon.2024.e39217_bib104","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.freeradbiomed.2009.03.016","article-title":"Distinct Nrf1\/2-independent mechanisms mediate as 3+-induced glutamate-cysteine ligase subunit gene expression in murine hepatocytes","volume":"46","author":"Thompson","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.heliyon.2024.e39217_bib105","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10216","article-title":"Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups","volume":"6","author":"Soeda","year":"2015","journal-title":"Nat. Commun."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2024.e39217_bib106","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1111\/j.1753-4887.2012.00493.x","article-title":"Defining the human microbiome","volume":"70","author":"Ursell","year":"2012","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.heliyon.2024.e39217_bib107","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12974-019-1494-4","article-title":"Antibiotics, gut microbiota, and Alzheimer's disease","volume":"16","author":"Angelucci","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e39217_bib108","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gtc.2016.09.007","article-title":"The microbiome-gut-brain Axis in health and disease","volume":"46","author":"Dinan","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.heliyon.2024.e39217_bib109","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s12264-023-01025-w","article-title":"C\/EBPbeta\/AEP signaling drives Alzheimer's disease pathogenesis","volume":"39","author":"Xiong","year":"2023","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.heliyon.2024.e39217_bib110","article-title":"Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD)","volume":"1","author":"Zhao","year":"2015","journal-title":"J. Nat. Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib111","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/iid3.266","article-title":"Relationship between oral and gut microbiota in elderly people","volume":"7","author":"Iwauchi","year":"2019","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.heliyon.2024.e39217_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1010853","article-title":"The oral-gut axis: salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease","volume":"12","author":"Abdelbary","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib113","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s12035-018-1188-4","article-title":"The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer's disease-a critical review","volume":"56","author":"Sochocka","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib114","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/obr.12661","article-title":"Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems","volume":"19","author":"Mulders","year":"2018","journal-title":"Obes. Rev."},{"key":"10.1016\/j.heliyon.2024.e39217_bib115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnagi.2015.00009","article-title":"Microbial-generated amyloids and Alzheimer's disease (AD)","volume":"7","author":"Hill","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib116","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s11427-016-5083-9","article-title":"Alzheimer's disease and gut microbiota","volume":"59","author":"Hu","year":"2016","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib117","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2012.01.010","article-title":"Prolonged elevation in hippocampal Abeta and cognitive deficits following repeated endotoxin exposure in the mouse","volume":"229","author":"Kahn","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.heliyon.2024.e39217_bib118","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3389\/fmicb.2016.01544","article-title":"Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer's disease","volume":"7","author":"Lukiw","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib119","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fncel.2019.00514","article-title":"Pharmacological targeting of microglial activation: new therapeutic approach","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib120","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3389\/fimmu.2019.01511","article-title":"Melatonin attenuates LPS-induced acute depressive-like behaviors and microglial NLRP3 inflammasome activation through the SIRT1\/nrf2 pathway","volume":"10","author":"Arioz","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2020.105674","article-title":"How microclimatic variables and blood meal sources influence Rhodnius prolixus abundance and Trypanosoma cruzi infection in Attalea butyracea and Elaeis guineensis palms?","volume":"212","author":"Calderon","year":"2020","journal-title":"Acta Trop."},{"key":"10.1016\/j.heliyon.2024.e39217_bib122","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOG.0000000000000156","article-title":"Bile acids as metabolic regulators","volume":"31","author":"Li","year":"2015","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib123","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1749-6632.2012.06513.x","article-title":"The link between altered cholesterol metabolism and Alzheimer's disease","volume":"1259","author":"Gamba","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib124","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1038\/ncomms7176","article-title":"Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques","volume":"6","author":"Condello","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e39217_bib125","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib126","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.heliyon.2024.e39217_bib127","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11910-017-0802-6","article-title":"Microbiota-brain-gut Axis and neurodegenerative diseases","volume":"17","author":"Quigley","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.heliyon.2024.e39217_bib128","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3389\/fnins.2019.01264","article-title":"MiR-409-5p as a regulator of neurite growth is down regulated in APP\/PS1 murine model of Alzheimer's disease","volume":"13","author":"Guo","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib129","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ebiom.2018.11.059","article-title":"A novel mechanism of synaptic and cognitive impairments mediated via microRNA-30b in Alzheimer's disease","volume":"39","author":"Song","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.heliyon.2024.e39217_bib130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41380-018-0266-3","article-title":"Novel upregulation of amyloid-beta precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5'-untranslated region: implications in Alzheimer's disease","volume":"24","author":"Long","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e39217_bib131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2010-091603","article-title":"MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study","volume":"21","author":"Nelson","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.heliyon.2024.e39217_bib132","doi-asserted-by":"crossref","first-page":"13748","DOI":"10.1074\/jbc.M112.381392","article-title":"MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10)","volume":"288","author":"Cheng","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e39217_bib133","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.15252\/embj.201387576","article-title":"MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease","volume":"33","author":"Banzhaf-Strathmann","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2024.e39217_bib134","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.15252\/emmm.201606520","article-title":"miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain","volume":"8","author":"Salta","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e39217_bib135","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.12437","article-title":"Alternative polyadenylation and miR-34 family members regulate tau expression","volume":"127","author":"Dickson","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.heliyon.2024.e39217_bib136","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/jnc.13212","article-title":"Activation of Cdk5\/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation","volume":"134","author":"Sun","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.heliyon.2024.e39217_bib137","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12035-013-8595-3","article-title":"Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells","volume":"50","author":"Zhao","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib138","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1471-4159.2011.07333.x","article-title":"Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR-743a","volume":"118","author":"Shi","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.heliyon.2024.e39217_bib139","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.7150\/thno.53418","article-title":"MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.heliyon.2024.e39217_bib140","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.7150\/thno.47408","article-title":"Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.heliyon.2024.e39217_bib141","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40035-022-00302-4","article-title":"Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer's disease","volume":"11","author":"Chen","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.heliyon.2024.e39217_bib142","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.biopsych.2017.07.023","article-title":"A novel MicroRNA-124\/PTPN1 signal pathway mediates synaptic and memory deficits in Alzheimer's disease","volume":"83","author":"Wang","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e39217_bib143","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12974-022-02548-1","article-title":"MicroRNA-22-3p ameliorates Alzheimer's disease by targeting SOX9 through the NF-kappaB signaling pathway in the hippocampus","volume":"19","author":"Xia","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e39217_bib144","doi-asserted-by":"crossref","first-page":"12581","DOI":"10.1523\/JNEUROSCI.3338-08.2008","article-title":"MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons","volume":"28","author":"Aschrafi","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib145","first-page":"91","article-title":"MicroRNA-98 reduces amyloid beta-protein production and improves oxidative stress and mitochondrial dysfunction through the Notch signaling pathway via HEY2 in Alzheimer's disease mice","volume":"43","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e39217_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021717","article-title":"Tacrine-based hybrids: past, present, and future","volume":"24","author":"Bubley","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib147","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2147\/CIA.S159920","article-title":"Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients","volume":"13","author":"Zhang","year":"2018","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.heliyon.2024.e39217_bib148","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1586\/ern.11.132","article-title":"Use of memantine for the treatment of dementia","volume":"11","author":"Lo","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.heliyon.2024.e39217_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061117","article-title":"Therapeutic approach to Alzheimer's disease: current treatments and new perspectives","volume":"14","author":"Pardo-Moreno","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2024.e39217_bib150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e39217_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heliyon.2024.e39217_bib152","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.heliyon.2024.e39217_bib153","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.heliyon.2024.e39217_bib154","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e39217_bib155","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2024.e39217_bib156","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jamaneurol.2022.2793","article-title":"Association of amyloid reduction after donanemab treatment with tau pathology and clinical outcomes: the TRAILBLAZER-ALZ randomized clinical trial","volume":"79","author":"Shcherbinin","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib157","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.heliyon.2024.e39217_bib158","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jamaneurol.2020.2416","article-title":"Error in the biomarker subsection","volume":"77","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.heliyon.2024.e39217_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093103","article-title":"Neural stem cell transplantation for neurodegenerative diseases","volume":"21","author":"De Gioia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e39217_bib160","article-title":"Alzheimer's disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.heliyon.2024.e39217_bib162","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1831","article-title":"Or combination therapy-what is the best therapy for Alzheimer's disease? A network meta-analysis","volume":"10","author":"Guo","year":"2020","journal-title":"Brain Behav"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024152486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024152486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:18:18Z","timestamp":1775729898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024152486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":161,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2405844024152486"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39217","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the multifaceted pathogenesis and therapeutic drugs of Alzheimer's disease: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e39217"}}